» Articles » PMID: 31891740

The Low Levels of Nerve Growth Factor and Its Upstream Regulatory Kinases in Prion Infection is Reversed by Resveratrol

Overview
Journal Neurosci Res
Publisher Elsevier
Specialty Neurology
Date 2020 Jan 1
PMID 31891740
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Resveratrol shows ability to eliminate prion replication, but the exact mechanism for prion eradication was not clear yet. Our previous studies demonstrate a downregulation of brain-derived nerve growth factor (BDNF) during prion infection, meanwhile recovery of cerebral nerve growth factor (NGF) level by resveratrol treatment has been reported in other neurodegenerative models. To obtain the possible changes of brain NGF and its upstream regulatory cascade during prion infection and after removal of prion propagation, the levels of NGF and its upstream regulatory factors in various prion-infected and prion-eradicated SMB cell lines and mice brains inoculated with various SMB cellular lysates were assessed with various methodologies. The levels of NGF were significantly decreased during prion replication, while recovered after removal of PrP by resveratrol in vitro. Morphological assays revealed that the NGF signals mainly colocalized within neurons, but not in the proliferative astrocytes and microglia. The upstream positive regulatory kinases, such as p-CREB, p-CaMKIV, CaMKK2 were decreased in the prion infected cells and mice brains, whereas the negative regulatory one, p-CaMKK2, was increased. The aberrant situations of those kinases in prion infected cell lines or mice brains could be also partially reversed by removal of prion agent. Moreover, we demonstrated that the signals of CaMKK2 and p-CaMKK2 were also distributed predominately in neurons in the brain tissues. The data illustrate a direct linkage of abnormally repressive NGF and its upstream regulatory kinases with prion infection. Resveratrol has not only the ability to inhibit prion replication, but also to improve the expression of NGF via CaMKK2/CaMKIV cascade, which might benefit the microenvironment in brains.

Citing Articles

Aberrance of GAP43/p-GAP43 Closely Associates with the Pathology of Neuron Loss in Prion-Infected Rodent Models.

Jia X, Chen C, Hu C, Wu Y, Chao Z, Zeng J Mol Neurobiol. 2024; 62(4):4435-4451.

PMID: 39453517 DOI: 10.1007/s12035-024-04568-9.


Resveratrol and Vitamin D: Eclectic Molecules Promoting Mitochondrial Health in Sarcopenia.

Russo C, Valle M, DAngeli F, Surdo S, Malaguarnera L Int J Mol Sci. 2024; 25(14).

PMID: 39062745 PMC: 11277153. DOI: 10.3390/ijms25147503.


Molecular signatures in prion disease: altered death receptor pathways in a mouse model.

Giri R J Transl Med. 2024; 22(1):503.

PMID: 38802941 PMC: 11129387. DOI: 10.1186/s12967-024-05121-x.


Extensive Disturbances of Intracellular Components and Dysfunctions of Biological Pathways in the Brain Tissues During Prion Infection - China's Studies.

Shi Q, Chen C, Xiao K, Zhou W, Gao C, Gao L China CDC Wkly. 2022; 4(33):741-747.

PMID: 36285114 PMC: 9547740. DOI: 10.46234/ccdcw2022.154.


Enhanced M-CSF/CSF1R Signaling Closely Associates with PrP Accumulation in the Scrapie-Infected Cell Line and the Brains of Scrapie-Infected Experimental Rodents.

Xia Y, Chen C, Chen J, Hu C, Yang W, Wang L Mol Neurobiol. 2022; 59(10):6534-6551.

PMID: 35970974 DOI: 10.1007/s12035-022-02989-y.